AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
MediPharm Labs Corp.
Video analysis: LABS.TO
All videosNo video analysis for this stock yet. Request one from our team.
News: LABS.TO
MediPharm Labs Sets Date to Report Second Quarter 2026 Financial Results
TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it will release its second quarter financial results for the three and six months ended June 30th, 2026, before markets open on Thursday, August 13th, 2026.
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders
TORONTO, June 17, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today announced the results of matters voted on at its annual and special meeting (the "Meeting") of holders of common shares ("Shareholders") held today.
Similar companies
-
Charlotte's Web Holdings, Inc.
CWEB.TO
·
Toronto Stock Exchange
Compare
-
Avicanna Inc.
AVCN.TO
·
Toronto Stock Exchange
Compare
-
Rubicon Organics Inc.
ROMJ.V
·
Toronto Stock Exchange Ventures
Compare
-
Voyageur Pharmaceuticals Ltd.
VM.V
·
Toronto Stock Exchange Ventures
Compare
-
Izotropic Corporation
IZO.CN
·
Canadian Securities Exchange
Compare
-
DIAGNOS Inc.
ADK.V
·
Toronto Stock Exchange Ventures
Compare